NASDAQ:AKER

Akers Biosciences News Headlines

$4.13
-0.07 (-1.67 %)
(As of 05/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.08
$4.28
50-Day Range
$2.47
$4.59
52-Week Range
$1.65
$6.97
Volume78,039 shs
Average Volume769,876 shs
Market Capitalization$68.78 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3

Headlines

Akers Biosciences (NASDAQ AKER) News Headlines Today

SourceHeadline
Akers Biosciences (NASDAQ:AKER) Share Price Passes Above Fifty Day Moving Average of $3.46Akers Biosciences (NASDAQ:AKER) Share Price Passes Above Fifty Day Moving Average of $3.46
americanbankingnews.com - May 4 at 2:42 AM
Akers Biosciences (NASDAQ:AKER) Share Price Crosses Above 50-Day Moving Average of $3.30Akers Biosciences (NASDAQ:AKER) Share Price Crosses Above 50-Day Moving Average of $3.30
americanbankingnews.com - April 24 at 2:32 AM
Akers Biosciences completes merger with MyMD Pharmaceuticals, relocates to BaltimoreAkers Biosciences completes merger with MyMD Pharmaceuticals, relocates to Baltimore
bizjournals.com - April 19 at 1:05 PM
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of MergerAkers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
finance.yahoo.com - April 16 at 2:29 PM
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression TrialAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial
finance.yahoo.com - April 13 at 9:56 AM
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory BoardAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board
finance.yahoo.com - April 12 at 12:21 PM
Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD PharmaceuticalsAkers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals
finance.yahoo.com - March 22 at 8:37 AM
We Think Akers Biosciences (NASDAQ:AKER) Can Afford To Drive Business GrowthWe Think Akers Biosciences (NASDAQ:AKER) Can Afford To Drive Business Growth
finance.yahoo.com - March 21 at 8:55 AM
MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery - MarketWatchMyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery - MarketWatch
marketwatch.com - February 24 at 10:12 AM
Study Identifies Effects of Temperature Changes on SARS-CoV-2 TransmissionStudy Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission
finance.yahoo.com - February 18 at 12:04 PM
Akers Biosciences Responds to Erroneous Earnings Call Press ReleaseAkers Biosciences Responds to Erroneous Earnings Call Press Release
finance.yahoo.com - February 17 at 3:46 PM
AKERS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AKER and Encourages Investors to Contact the FirmAKERS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of AKER and Encourages Investors to Contact the Firm
finance.yahoo.com - February 11 at 2:56 PM
Rapid Tests Market Analysis Report contains all study material about Market Overview, Growth, Demand and Forecast Research with Top Countries DataRapid Tests Market Analysis Report contains all study material about Market Overview, Growth, Demand and Forecast Research with Top Countries Data
marketwatch.com - February 5 at 11:04 PM
Global Rapid Tests Market Share - 2021, Size, Growth & value, Competitive Situation and Trends, Business Revenues, Opportunities and Drivers 2027Global Rapid Tests Market Share - 2021, Size, Growth & value, Competitive Situation and Trends, Business Revenues, Opportunities and Drivers 2027
marketwatch.com - February 5 at 7:50 AM
Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key PatentAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent
finance.yahoo.com - December 2 at 3:55 PM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS MergersSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers
finance.yahoo.com - December 1 at 3:46 PM
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKERSHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKER
finance.yahoo.com - November 18 at 8:29 PM
REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD PharmaceuticalsREMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals
businesswire.com - November 18 at 8:53 AM
AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKERAKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER
finance.yahoo.com - November 18 at 12:19 AM
AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKERAKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER
businesswire.com - November 17 at 8:30 PM
RM LAW Announces Investigation of Akers Biosciences, Inc.RM LAW Announces Investigation of Akers Biosciences, Inc.
finance.yahoo.com - November 17 at 7:19 PM
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. MergerSHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. Merger
finance.yahoo.com - November 13 at 2:19 PM
Akers Biosciences shares are trading higher after the company and MyMD Pharmaceuticals signed a definitive merger agreement.Akers Biosciences shares are trading higher after the company and MyMD Pharmaceuticals signed a definitive merger agreement.
benzinga.com - November 13 at 12:08 AM
Akers Biosciences stock soars 29% on merger dealAkers Biosciences' stock soars 29% on merger deal
bizjournals.com - November 13 at 12:08 AM
Why Akers Biosciences Stock Is Trading Higher TodayWhy Akers Biosciences Stock Is Trading Higher Today
benzinga.com - November 12 at 7:08 PM
Akers BioSciences rallies 37% on tie-up with MyMD PharmaAkers BioSciences rallies 37% on tie-up with MyMD Pharma
seekingalpha.com - November 12 at 2:07 PM
MyMD Pharma, Akers Biosciences To MergeMyMD Pharma, Akers Biosciences To Merge
nasdaq.com - November 12 at 2:07 PM
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger AgreementAkers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
finance.yahoo.com - November 12 at 2:07 PM
Akers Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Akers Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AKERAkers Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Akers Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AKER
finance.yahoo.com - November 12 at 2:07 PM
Global Oral Anticoagulant Market 2020 Research with COVID-19 Impact Analysis - Segmentation, Regional Outlook and Competition Analysis to 2026Global Oral Anticoagulant Market 2020 Research with COVID-19 Impact Analysis - Segmentation, Regional Outlook and Competition Analysis to 2026
marketwatch.com - November 12 at 12:33 AM
Akers Biosciences Inc. Common Stock (AKER)Akers Biosciences Inc. Common Stock (AKER)
nasdaq.com - November 2 at 1:16 PM
Akers Biosciences down 28% on early data on COVID-19 vaccine candidateAkers Biosciences down 28% on early data on COVID-19 vaccine candidate
seekingalpha.com - August 27 at 2:54 PM
Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept ResultsAkers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results
finance.yahoo.com - August 27 at 9:53 AM
Akers Biosciences raises $6.8M in equityAkers Biosciences raises $6.8M in equity
seekingalpha.com - August 11 at 4:12 PM
Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesAkers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - August 11 at 4:12 PM
Breath Sampler Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2024Breath Sampler Market 2020 Global Industry Brief Analysis by Top Countries Data with Market Size is expected to see magnificent growth Till 2024
www.marketwatch.com - July 29 at 8:04 AM
Why Akers Biosciences Is Trading Higher TodayWhy Akers Biosciences Is Trading Higher Today
www.benzinga.com - July 20 at 3:10 PM
BRIEF-Akers Biosciences, Premas Biotech Announce Initiation Of Animal Studies For Sars-Cov-2 Vaccine Candidate In IndiaBRIEF-Akers Biosciences, Premas Biotech Announce Initiation Of Animal Studies For Sars-Cov-2 Vaccine Candidate In India
www.reuters.com - July 7 at 12:47 PM
Akers Biosciences and Premas Biotech Announce Initiation of Animal StudiesAkers Biosciences and Premas Biotech Announce Initiation of Animal Studies
finance.yahoo.com - July 7 at 12:47 PM
Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid TestAkers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
www.bloomberg.com - June 21 at 6:36 PM
Hedge Funds Are Nibbling On Akers Biosciences Inc (AKER)Hedge Funds Are Nibbling On Akers Biosciences Inc (AKER)
finance.yahoo.com - May 29 at 3:35 PM
BRIEF-Akers Files For Offer Of Up To 793,437 Common Shares By The Selling StockholdersBRIEF-Akers Files For Offer Of Up To 793,437 Common Shares By The Selling Stockholders
www.reuters.com - May 22 at 6:20 PM
Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesAkers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - May 18 at 6:39 PM
South Jersey company working on Covid-19 vaccine raising $4.8MSouth Jersey company working on Covid-19 vaccine raising $4.8M
www.bizjournals.com - May 15 at 2:42 PM
BRIEF-Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesBRIEF-Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
www.reuters.com - May 14 at 11:40 PM
BRIEF-Akers Biosciences Says On May 14, Co And Sellers Entered Into Amendment No. 1 To Membership Interest Purchase AgreementBRIEF-Akers Biosciences Says On May 14, Co And Sellers Entered Into Amendment No. 1 To Membership Interest Purchase Agreement
www.reuters.com - May 14 at 6:40 PM
Microcap Akers Biosciences Spikes on Covid-Vaccine ProgressMicrocap Akers Biosciences Spikes on Covid-Vaccine Progress
finance.yahoo.com - May 14 at 6:40 PM
Akers up 31% on advancement of COVID-19 vaccine candidateAkers up 31% on advancement of COVID-19 vaccine candidate
seekingalpha.com - May 14 at 1:39 PM
Stock Alert: Akers Biosciences Jumps 22%Stock Alert: Akers Biosciences Jumps 22%
www.nasdaq.com - May 14 at 1:39 PM
Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLPAkers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP
finance.yahoo.com - May 14 at 1:39 PM
This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.